Australia’s active vaccine safety system

AusVaxSafety commenced routine safety monitoring of 2025 seasonal influenza vaccines used in Australia across all ages in March 2025.

The influenza vaccines in use in Australia in 2025 are:

Standard influenza vaccines

  • Afluria Quad (individuals aged 5 years and older)
  • Flucelvax Quad (individuals aged 6 months and older)
  • FluQuadri (individuals aged 6 months and older)
  • Influvac Tetra (individuals aged 6 months and older)
  • Vaxigrip Tetra (individuals aged 6 months and older).

Adjuvanted or high-dose vaccines

  • Fluad Quad (individuals aged 65 years and over)
  • Fluzone High-Dose (individuals aged 60 years and over).

Surveillance data are gathered via AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination.
 


Latest influenza vaccine safety data

Click on the tiles below to view 2025 AusVaxSafety influenza vaccine safety data for specific age and population groups.